Abstract
Background and aims
Methods
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Digestive and Liver DiseaseReferences
- AGA clinical practice update: coagulation in cirrhosis.Gastroenterology. 2019; 157 (e31): 34-43https://doi.org/10.1053/j.gastro.2019.03.070
- Portal vein thrombosis associated with high 14-day and 6-week rebleeding in patients after oesophageal variceal band ligation: a retrospective, multicentre, nested case-control study.Hepatol Int. 2021; 15: 1183-1195https://doi.org/10.1007/s12072-021-10224-4
- De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes.Am J Gastroenterol. 2013; 108: 568-574https://doi.org/10.1038/ajg.2012.452
- Portal vein thrombosis in decompensated cirrhosis: rationale for treatment.Clin Transl Gastroenterol. 2019; 10: e00026https://doi.org/10.14309/ctg.0000000000000026
- Current knowledge and management of portal vein thrombosis in cirrhosis.J Hepatol. 2021; 75: 442-453https://doi.org/10.1016/j.jhep.2021.04.029
- Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study.Liver Int. 2018; 38: 94-101https://doi.org/10.1111/liv.13500
- Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors.J Hepatol. 2021; 75: 1367-1376https://doi.org/10.1016/j.jhep.2021.07.020
- Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.J Hepatol. 2022; 76: 1090-1099https://doi.org/10.1016/j.jhep.2021.12.038
- Viscoelastic tests in liver disease: where do we stand now?.World J Gastroenterol. 2021; 27: 3290-3302https://doi.org/10.3748/wjg.v27.i23.3290
- Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: a randomized controlled trial.Hepatology. 2020; 71: 235-246https://doi.org/10.1002/hep.30794
- Thromboelastography parameters are associated with cirrhosis severity.Dig Dis Sci. 2019; 64: 2661-2670https://doi.org/10.1007/s10620-019-05597-4
- Reduced clot stability by thromboelastography as a potential indicator of procedure-related bleeding in decompensated cirrhosis.Hepatol Commun. 2021; 5: 272-282https://doi.org/10.1002/hep4.1641
- Thromboelastography better reflects hemostatic abnormalities in cirrhotics compared with the international normalized ratio.J Clin Gastroenterol. 2020; 54: 741-746https://doi.org/10.1097/MCG.0000000000001285
- Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma.Dig Liver Dis. 2017; 49: 440-445https://doi.org/10.1016/j.dld.2016.12.019
- Systemic inflammation and portal vein thrombosis in cirrhotic patients with gastroesophageal varices.Eur J Gastroenterol Hepatol. 2020; 32: 401-405https://doi.org/10.1097/MEG.0000000000001526
- Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis.BMC Gastroenterol. 2021; 21: 253https://doi.org/10.1186/s12876-021-01832-3
- Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study.Liver Int. 2019; 39: 1459-1467https://doi.org/10.1111/liv.14121
- Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes.Thromb Haemost. 2014; 111: 713-724https://doi.org/10.1160/TH13-08-0643
- Assessing the methodology for calculating platelet contribution to clot strength (platelet component) in thromboelastometry and thrombelastography.Anesth Analg. 2015; 121: 868-878https://doi.org/10.1213/ANE.0000000000000859
- Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death.J Hepatol. 2022; 77: 660-669https://doi.org/10.1016/j.jhep.2022.03.009
- Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS.Gut. 2020; 69: 1535-1536https://doi.org/10.1136/gutjnl-2019-319044
- Low-grade endotoxemia and platelet activation in cirrhosis.Hepatology. 2017; 65: 571-581https://doi.org/10.1002/hep.28853
- Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation.J Thromb Thrombolysis. 2017; 43: 54-59https://doi.org/10.1007/s11239-016-1401-0
- Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features.Hepatology. 2020; 72: 1327-1340https://doi.org/10.1002/hep.31443
- Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections.JHEP Rep. 2022; 4100493https://doi.org/10.1016/j.jhepr.2022.100493
- Baveno VII - Renewing consensus in portal hypertension.J Hepatol. 2022; 76: 959-974https://doi.org/10.1016/j.jhep.2021.12.022
- Spontaneous portosystemic shunts in cirrhosis: detection, implications, and clinical associations.Dig Liver Dis. 2021; 53: 1468-1475https://doi.org/10.1016/j.dld.2020.11.020
- Platelet count/spleen volume ratio has a good predictive value for esophageal varices in patients with hepatitis B liver cirrhosis.PLoS One. 2021; 16e0260774https://doi.org/10.1371/journal.pone.0260774
- Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.Gut. 2015; 64: 531-537https://doi.org/10.1136/gutjnl-2014-308874
- Strengths and weaknesses of light transmission aggregometry in diagnosing hereditary platelet function disorders.J Clin Med. 2020; 9https://doi.org/10.3390/jcm9030763
- Association between thrombogenicity indices and coronary microvascular dysfunction in patients with acute myocardial infarction.JACC Basic Transl Sci. 2021; 6: 749-761https://doi.org/10.1016/j.jacbts.2021.08.007
- Association of thrombelastographic parameters with post-stenting ischemic events.J Neurointerv Surg. 2017; 9: 192-195https://doi.org/10.1136/neurintsurg-2015-011687
- Stored platelet number and viscoelastic maximum amplitude are not altered by warming or rapid infusion.Transfusion. 2019; 59: 2997-3001https://doi.org/10.1111/trf.15446
- Platelet activation assessed by glycoprotein VI/platelet ratio is associated with portal vein thrombosis after hepatectomy and splenectomy in patients with liver cirrhosis.Clin Appl Thromb Hemost. 2018; 24: 254-262https://doi.org/10.1177/1076029617725600
- Risk factors of portal vein thrombosis after devascularization treatment in patients with liver cirrhosis: a nested case-control study.Biomed Res Int. 2020; 20209583706https://doi.org/10.1155/2020/9583706
- Improvement of human platelet aggregation post-splenectomy with paraesophagogastric devascularization in chronic hepatitis B patients with cirrhotic hypersplenism.Platelets. 2020; 31: 1019-1027https://doi.org/10.1080/09537104.2019.1704715
- Entecavir as a P2X7R antagonist ameliorates platelet activation and thrombus formation.J Pharmacol Sci. 2020; 144: 43-51https://doi.org/10.1016/j.jphs.2020.07.002
- Fibrinogen measurement in liver disease: validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model.Blood Transfus. 2019; 17: 237-246https://doi.org/10.2450/2018.0105-18
- Platelet biology and functions: new concepts and clinical perspectives.Nat Rev Cardiol. 2019; 16: 166-179https://doi.org/10.1038/s41569-018-0110-0
- The pathophysiology of portal vein thrombosis in cirrhosis: getting deeper into virchow's triad.J Clin Med. 2022; 11: 800https://doi.org/10.3390/jcm11030800
- Shear-dependent platelet aggregation: mechanisms and therapeutic opportunities.Front Cardiovasc Med. 2019; 6: 141https://doi.org/10.3389/fcvm.2019.00141
- Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients.Dig Liver Dis. 2022; 54: 103-110https://doi.org/10.1016/j.dld.2020.12.114
- Platelet consumption and hyperreactivity coexist in experimental traumatic hemorrhagic model.Platelets. 2020; 31: 777-783https://doi.org/10.1080/09537104.2019.1678120
- Thrombin induced platelet-fibrin clot strength measured by thrombelastography is a novel marker of platelet activation in acute myocardial infarction.Int J Cardiol. 2014; 172: e24-e25https://doi.org/10.1016/j.ijcard.2013.12.092
Article info
Publication history
Publication stage
In Press Corrected ProofFootnotes
Grant support: This study was supported by the Sichuan Science and Technology Program (Grant No. 22ZDYF0621), 1·3·5 project for disciplines of excellence – Clinical Research Incubation Project (2019HXFH024), West China Hospital, Sichuan University, Technological innovation R&D project of Chengdu Science and Technology Bureau (2021-YF05-01285-SN), National Natural Science Foundation of China (Grant No. 82270649) and Sichuan Science and Technology Program (2020YFS0236).
Conflict of Interest: The authors have no conflicts of interest to disclose.